
The move comes as FDA’s grace period for compounded GLP-1s comes to an end.
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
The move comes as FDA’s grace period for compounded GLP-1s comes to an end.
The two companies first announced the merger back in March of this year.
The LRA CEO discusses his work with the organization and recent trends in Lupus R&D.
Across the board, oncologists are navigating a fast-changing landscape while managing full patient loads, reimbursement pressures, and evolving care standards.
Demand for semaglutide and other GLP-1s is expected to grow exponentially over the next 3–5 years.
The ad is the latest DTC content from SK Life Science.
Supernus Pharmaceuticals’ campaign aims to raise awareness about issues women face even getting diagnosed with ADHD.
Genovese discusses recent data that shows Omvoh’s effectiveness at treating IBD.
The film tells the story of a family impacted by the disease and shares the importance of checking to make sure that children are vaccinated against all strains.
The ability to predict side effects such as nausea before starting treatment represents a paradigm shift in precision medicine.
Research has shown a gap between the female patient experience compared to those of men.
The organization believes that the proposed cuts will be harmful to Americans suffering from mental illnesses.
The protection and privacy of healthcare data is a massive hurdle for the new technology to overcome.
Reshema Kemps-Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of the Year, uses the lessons she learned from her family to bring out the best in her teams.
The campaign promotes women to have conversations with their family members about heart health history.
Groups like PhRMA and the HDA issued statements explaining their stance of the drug-pricing policy.
Stricter regulations on a fragmented media landscape is forcing the industry to rethink marketing.
The order pushes drug companies to reduce drug prices in the United States to fall in line with other countries around the world.
The President plans to sign an executive order on Monday morning to enforce the trade clause.
Proposed cuts to Medicaid could cause serious issues in rural areas of the United States.
The provider hopes that this option will be a solution to the state’s primary care physician shortage.
The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.
The company shifted several key presidents to adjust its global priorities.
Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.
The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years.
The program will send 11 young soccer players to learn from professional soccer coaches in Madrid.
Pharma companies have opportunities to grow, but they also must plan for a complicated future.
The campaign provides information about early signs of the condition along with treatment information.
ConnectING with Carnie promotes the importance of routine screening and treatment options for the involuntary movement condition.
In the face of potential tariffs, the pharmaceutical industry must find alternative ways to reduce costs.